Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

706results about "Protein nucleotide libraries" patented technology

Continuous directed evolution

The invention provides systems, methods, reagents, apparatuses, vectors, and host cells for the continuous evolution of nucleic acids. For example, a lagoon is provided in which a population of viral vectors comprising a gene of interest replicates in a stream of host cells, wherein the viral vectors lack a gene encoding a protein required for the generation of infectious viral particles, and wherein that gene is expressed in the host cells under the control of a conditional promoter, the activity of which depends on a function of the gene of interest to be evolved. Some aspects of this invention provide evolved products obtained from continuous evolution procedures described herein. Kits containing materials for continuous evolution are also provided.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

High-throughput single-nucleus and single-cell libraries, and methods of production and use

To provide high-throughput single-nucleus and single-cell libraries, and methods of production and use.SOLUTION: Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells. In one embodiment, the method includes nuclear or cellular hashing which permits increased sample throughput and increased doublet detection at high collision rates. In one embodiment, the method includes normalization hashing, which aids in estimating and removing technical noise in cell-to-cell variation and increases sensitivity and specificity.SELECTED DRAWING: None
Owner:ILLUMINA INC +1

Synthetic combinatorial AAV3 capsid library

Compositions and methods for producing modified AAV Cap genes and combinatorial libraries of chimeric AAV vectors and virions in an AAV serotype 3 background. Selecting for modified AAV3 virions displaying cell- or tissue-specific tropisms differing from WT AAV3. Using the synthetic combinatorial AAV3 capsid libraries for introducing into a selected target host cells one or more nucleic acid molecules useful in diagnostic and / or therapeutic gene-therapy regimens.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Rubber tree chloroplast SNP (Single Nucleotide Polymorphism) marker-based rubber tree B-type cultivated variety identification method

The invention belongs to the technical field of molecular markers, and particularly relates to a rubber tree chloroplast SNP marker-based rubber tree B-type cultivated variety identification method, 19 SNP loci are involved in total, an SNP marker combination provided by the invention can be used for identifying rubber tree varieties with higher yield, and by utilizing the SNP marker combination provided by the invention, the yield of the rubber tree varieties is increased. And variety improvement and new variety breeding can be more accurately carried out, so that good varieties with higher yield are selected, and the planting benefits of the rubber trees are improved.
Owner:SANYA RES INST OF CHINESE ACAD OF TROPICAL AGRI +1

Library of antigen-binding molecules including modified antibody variable region

The present inventors have successfully prepared a library consisting essentially of a plurality of antigen-binding molecules differing in sequence from each other, the antigen-binding molecules each comprising an antibody variable region that has binding activity against a first antigen and a second antigen different from the first antigen, but does not bind to the first antigen and the second antigen at the same time. Use of the library of the present invention allows the obtainment of a variable region having enhanced ability to bind to the first antigen and the production of a bispecific antibody against the first antigen and a cancer antigen. Moreover, the present inventors have also successfully prepared an antigen-binding molecule comprising an antibody variable region that has binding activity against three different antigens, but does not bind to these antigens at the same time.
Owner:CHUGAI PHARMA CO LTD

Dual-tagmentation single-cell dnaseq

PCT designated stage expiredWO2025024703A1Microbiological testing/measurementSequence analysisShort readChromatosome
Methods of sequencing long chromosomal fragments using short read sequencing methods by using two separate transposase-based fragmentation steps.
Owner:BIO RAD LABORATORIES INC

Virus-derived construct plasmid library and construction of same

In one aspect, the present disclosure provides a method for producing various virus-derived construct plasmids from starting plasmids (for example, virus-derived construct plasmids of the present disclosure). In one embodiment, a method for producing virus-derived construct plasmids of the present disclosure includes a step of preparing a set of starting plasmids containing at least of a part of nucleic acid sequences required to construct a virus-derived construct, the set of starting plasmids including a set of corresponding alternative unit nucleic acids, and the set of corresponding alternative unit nucleic acids including at least one set of corresponding alternative unit nucleic acids containing different nucleic acid sequences; a step of treating the set of starting plasmids with a restriction enzyme and preparing a mixed solution containing cleaved alternative unit nucleic acid fragments; a step of ligating the cleaved alternative unit nucleic acid fragments to form an integrated nucleic acid; and a step of bringing the integrated nucleic acid into contact with a transformed organism to form virus-derived construct plasmids.
Owner:SYNPLOGEN CO LTD

Simplified genome sequencing library construction method and kit and related application thereof

The invention provides a simplified genome sequencing library construction method and a kit and related application thereof. The construction method of the simplified genome sequencing library comprises the following steps: (1) respectively carrying out enzyme digestion on a plurality of DNA (Deoxyribonucleic Acid) samples by using restriction endonuclease; wherein restriction endonucleases adopted by all the samples are different from one another, and the tail ends of specific DNA fragments of the samples are generated to serve as sample bar codes of the samples; (2) mixing the enzyme digestion products of the samples, constructing a DNA library, carrying out fragment sorting on the DNA library, and taking the selected library as a simplified genome sequencing library; or carrying out fragment sorting on the enzyme digestion product of each sample, and carrying out DNA library construction by using the selected fragments to obtain the simplified genome sequencing library. According to the method, the experimental operation process is simplified, the library building efficiency is improved, and meanwhile, the feasibility of the restriction endonuclease for recognizing 6 basic groups based on a third-generation long-read-long sequencing platform in the simplified genome sequencing technology is also explored.
Owner:HUAZHONG AGRI UNIV +1

Cellular data library and methods of using the same

PCT designated stage expiredWO2025054244A1Microorganism librariesRecombinant DNA-technology
The disclosure relates, inter alia, to a library of transcriptional data, and methods for assembling and using same.
Owner:CELLARITY INC

Method for analyzing g-protein conjugated receptor

PendingEP4541896A1Compound screeningFungiOrganic chemistryVertebrate
Provided is an approach which can express and function a G protein-coupled receptor (GPCR). The present invention provides a method for expressing a GPCR polypeptide, comprising expressing in a cell a GPCR polypeptide consisting of an amino acid sequence obtained by, in an amino acid sequence of a GPCR of interest (provided that an olfactory receptor is excluded), altering at least one amino acid residue different from that in a consensus amino acid sequence to an amino acid residue at a position corresponding thereto in the consensus amino acid sequence, wherein the consensus amino acid sequence is an amino acid sequence derived by alignment of the amino acid sequence of the GPCR of interest and amino acid sequences of GPCRs encoded by orthologs of the GPCR of interest in vertebrates.
Owner:KAO CORP

CAR library and scFv manufacturing method

Provided are a CAR library used to screen scFvs that can be functional in CAR-T cells, and an scFv manufacturing method in which the CAR library is used. A chimeric antigen receptor (CAR) library of the present invention includes nucleic acids coding for first CARs. Each of the first CARs includes a first antigen-binding domain, a first transmembrane domain, and a first intracellular signaling domain. The first antigen-binding domain includes a first single-chain antibody (scFv) to be screened for the ability to bind to a target antigen. The first scFv includes a first heavy-chain variable region and a first light-chain variable region. The first heavy-chain variable region and the first light-chain variable region meet a predetermined condition.
Owner:NAT UNIV CORP EHIME UNIV

Compositions and methods for multiplexed activation and repression of t cell gene expression

Provided herein are epigenetic-modifying DNA-targeting systems, such as CRISPR-Cas / guide RNA (gRNA) systems, that bind to or target multiple genes or regulatory elements thereof, for instance in a T cell. In some aspects, the provided epigenetic-modifying DNA-targeting systems promote increased transcription of one or more first genes and promote repressed transcription of one or more second genes. In some aspects, the provided epigenetic-modifying DNA-targeting systems modulate a T cell function, such as a T cell phenotype or activity. Also provided herein are polynucleotides, vectors, cells, methods, and uses related to the provided epigenetic-modifying DNA-targeting systems, for example in modulating T cells, such as in connection with methods of adoptive T cell therapy.
Owner:TUNE THERAPEUTICS INC

Anti-CD38 antibodies and uses thereof

ActiveJP7720871B2FungiBacteria
The present invention relates to compositions and methods related to antibodies or antibody fragments that specifically bind to CD38. The composition comprises an antibody or antibody fragment, wherein the antibody or antibody fragment comprises, as a component thereof, one or more complementarity determining regions or framework regions of a light chain variable region or a heavy chain variable region that comprises an amino acid sequence selected from the group consisting of predetermined amino acid sequences.
Owner:JIANGSU KANION PHARMA CO LTD

Library construction method, universal joint and kit

The embodiment of the invention provides a library construction method, a universal joint and a kit, relates to the technical field of synthetic biology, and is used for constructing a mixed library in which multiple gene segments are directionally connected. The library construction method comprises the following steps: providing a plurality of first initial gene segments; introducing cutting sequences to two ends of each first initial gene segment to obtain a plurality of second initial gene segments; introducing universal joints to two ends of each second initial gene segment to obtain a plurality of target gene segments; wherein the universal joint comprises an identification sequence; performing cutting and connection reaction on the plurality of target gene segments to obtain a mixed library; wherein the plurality of target gene segments are connected according to a set sequence. The library construction method is used for constructing the DNA mixed library.
Owner:BOE TECHNOLOGY GROUP CO LTD +1

Vectors for eliciting immune responses against nondominant epitopes within the hemagglutinin (HA) protein.

Methods are provided for producing influenza viruses with altered immunodominant epitopes within their HAs (e.g., with one or more altered residues in one or more of antigenic sites A-E within their HAs), as well as other viral vectors (e.g., influenza VLPs, or non-influenza viruses, or VLPs thereof) that express or have influenza HAs with altered immunogenicity as a result of altering the immunodominant epitopes contained therein.
Owner:WISCONSIN ALUMNI RES FOUND

Method for screening externally-introduced mRNA capable of existing for long time in cell

The present disclosure relates to a method of screening for and producing an mRNA sequence with improved intracellular stability that can exist in cells for a long period of time. According to a method according to an aspect, an mRNA sequence with improved intracellular stability can be screened for and produced by introducing a variation into a nucleotide sequence encoding a target protein such that there is no change in an amino acid sequence of the target protein. When the method is used, there is the advantage of improving the expression level of the target protein in vivo.
Owner:RNAGENE INC

Primer composition for amplifying coding sequence of heavy chain CDR3 of human B cell receptor and application of primer composition

The invention is applicable to the technical field of biotechnology, and particularly relates to a primer composition for amplifying a coding sequence of a human B cell receptor heavy chain CDR3 and application of the primer composition, and two primer groups, namely a first primer group and a second primer group, are designed. The two primers are respectively used as an upstream primer and a downstream primer, and comprise at least one human IGH CDR3 upstream primer and at least one human IGH CDR3 downstream primer. The primers can be respectively combined with nucleic acid of human B cells, and a basis for researching a CDR3 region of a B cell receptor is provided. The first primer group and the second primer group are combined with the nucleic acid of the human B cell, so that the coding sequence of the heavy chain of the human B cell receptor is effectively enriched, part of pseudogenes are contained, the amplification efficiency of the heavy chain CDR3 library of the human B cell receptor can be improved, and the deep research on immune response of the human B cell is promoted.
Owner:JIUJIANG MATERNAL & CHILD HEALTH HOSPITAL (JIUJIANG CHILDRENS HOSPITAL JIUJIANG MATERNAL & CHILD HEALTH & FAMILY PLANNING SERVICE CENT) +1

Pre-templated instant partitioning of dna-encoded libraries

This disclosure provides a powerful screening platform that combines pre-templated instant partitions with DNA-encoded library (DEL) technologies to identify target small molecule interactions and analyze their intracellular effects in single cell resolution using methods that require minimal sample preparation and affordable sequencing costs. These methods are well suited for rapidly evaluating drug candidates by simultaneously detecting novel target-binding molecules while screening their transcriptional effects with a single affordable, high throughput workflow.
Owner:FLUENT BIOSCIENCES INC

Single cell sequencing libraries of genomic transcript regions of interest in proximity to barcodes, and genotyping of said libraries

The present invention relates to methods of detecting region(s) of interest in a gene comprising a polyA tail. The region(s) of interest can include gene(s), region(s), mutation(s), deletion(s), insertion(s), indel(s), and / or translocation(s). The region(s) can be greater than or less than 1 kilobases from the polyA tail. Methods can include forming a library of single cell transcripts comprising the region(s) in close proximity to a cell barcode and a unique molecular identifier (UMI). Methods for distinguishing cells by genotype can include amplifying the transcripts using PCR methods and detecting the cell barcode and UMI using single cell sequencing methods. Transcripts can be enriched using tagged region-specific PCR primers. Cell barcodes can be brought into close proximity to the region(s) by circularizing the transcripts. Sequencing of the transcripts can include using primer binding sites added during PCR amplification and library indexes for multiplexed sequencing.
Owner:THE GENERAL HOSPITAL CORP +1

Novel polypeptide

PendingJP2025519203A5FungiBacteria
The present invention provides an hBCMA-binding polypeptide comprising at least one motif that binds to hBCMA, wherein the peptide has the following structure: [N-terminal portion]-[Helix 1]-[Spacer portion]-[Helix 2]-[C-terminal portion], and the hBCMA-binding motif is the portion [Helix 1]-[Spacer portion]-[Helix 2]. The present invention further provides a pharmaceutical composition comprising the hBCMA-binding polypeptide, and the use of the hBCMA-binding polypeptide or the pharmaceutical composition for use as a medicament, particularly for the treatment or prevention of cancer.
Owner:ONCOPEPTIDES INNOVATION 1 AB

Genetically encoded bicyclic peptide libraries

The present invention relates to a bicyclic peptide complex comprising a peptide construct, the construct comprising: (i) a polypeptide having a free terminus (N or C); (ii) optionally a nucleic acid encoding the polypeptide; and (iii) a dyad-symmetric linker (TSL) compound attached to the polypeptide, wherein the linker is attached to the terminus of the polypeptide and to at least two distinct side chains of the peptide via a covalent bond. The present invention also relates to a library and methods for making the complex, and to screening methods using the same.
Owner:48HOUR DISCOVERY INC